Why the study?
Do CMR-derived measures and molecular biomarkers correlate with myocardial fibrosis and function in individuals with hypertensive heart disease?
Do CMR-derived measures and molecular biomarkers correlate with myocardial fibrosis and function in individuals with hypertensive heart disease?
CMR-derived measures of fibrosis and function are related in hypertensive heart disease, while molecular biomarkers show limited association with imaging findings.
Answers are grounded in this paper and cite their sources.
May support CMR for fibrosis-function assessment in hypertensive heart disease; leaves open molecular biomarkers' added value pending prospective validation.
In individuals with HHD, CMR-derived measures of myocardial fibrosis and function are related and might be useful tools for the identification and characterization of preclinical cardiac dysfunction and diffuse myocardial fibrosis. Molecular biomarkers of fibrosis were marginally associated with myocardial strain, but not with the extension of CMR-measured cardiac fibrosis.
No takes yet. Share an insight, caveat, or question.
Pichler et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: